Effect of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Antagonists in Atherosclerosis Prevention

Angiotensin converting enzyme inhibitors effect on endothelial dysfunction: A meta-analysis of randomised controlled trials

(2011) Yousef Shahin et al.   ATHEROSCLEROSIS

Telmisartan protects against diabetic vascular complications in a mouse model of obesity and type 2 diabetes, partially through peroxisome proliferator activated receptor-γ-dependent activity

(2011) Kensuke Toyama et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Renin-Angiotensin-Aldosterone Blockade for Cardiovascular Disease Prevention

(2011) Krishnaswami Vijayaraghavan et al.   CARDIOLOGY CLINICS

Effects of ACE Inhibitors on Cardiac Angiotensin II and Aldosterone in Humans: “Relevance of Lipophilicity and Affinity for ACE”

(2010) Marcel Ruzicka et al.   AMERICAN JOURNAL OF HYPERTENSION

Telmisartan improves absolute walking distance and endothelial function in patients with peripheral artery disease

(2010) A. R. Zankl et al.   Clinical Research in Cardiology

Combination therapy for treatment or prevention of atherosclerosis: Focus on the lipid-RAAS interaction

(2009) Kwang Kon Koh et al.   ATHEROSCLEROSIS

Angiotensin II receptor antagonism with telmisartan increases number of endothelial progenitor cells in normotensive patients with coronary artery disease: A randomized, double-blind, placebo-controlled study

(2009) Francesco Pelliccia et al.   ATHEROSCLEROSIS

Inhibition of renin–angiotensin system attenuates periadventitial inflammation and reduces atherosclerotic lesion formation

(2009) Daiju Fukuda et al.   BIOMEDICINE & PHARMACOTHERAPY

Q: Is an ACE inhibitor plus an ARB more effective than either drug alone?

(2009) F. H. MESSERLI et al.   CLEVELAND CLINIC JOURNAL OF MEDICINE

Vascular protection in peripheral artery disease: systematic review and modelling study

(2009) D G Hackam et al.   HEART

The Sudden Demise of Dual Renin-Angiotensin System Blockade or the Soft Science of the Surrogate End Point

(2009) Franz H. Messerli   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Distinct vascular and metabolic effects of different classes of anti-hypertensive drugs

(2008) Kwang Kon Koh et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events

(2008)   NEW ENGLAND JOURNAL OF MEDICINE